Position in XNCR
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,201,800
+$481,794 QoQ
Shares Held
74,646
+25.0% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#67
of 208 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. XNCR ranks #54 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in XNCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,201,800 | 74,646 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $720,006 | 59,702 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $897,763 | 58,639 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $399,207 | 34,033 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $301,816 | 38,399 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $547,523 | 51,459 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $1,300,323 | 56,585 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $966,949 | 48,083 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $910,476 | 48,097 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $953,935 | 43,106 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $853,955 | 40,224 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $900,765 | 44,703 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,108,468 | 44,392 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,103,133 | 39,553 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,057,744 | 40,620 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $845,960 | 32,562 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $966,708 | 35,320 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $2,715,281 | 67,679 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $2,334,667 | 71,484 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,627,586 | 76,184 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,513,893 | 104,828 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $4,514,221 | 103,466 | Shares | Defined | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||